A field-ready LOI framework built for healthcare staffing deals — covering purchase price structures, earnout mechanics tied to contract retention, and the compliance-specific provisions every buyer and seller needs before entering exclusivity.
In a medical staffing agency acquisition, the Letter of Intent is more than a price placeholder — it is the document that sets the tone for how credentialing risk, client concentration, recruiter retention, and compliance exposure will be allocated between buyer and seller. Unlike a traditional service business, medical staffing agencies carry layered regulatory obligations including Joint Commission standards, state nursing board licensing, and ACA employer requirements that must be surfaced and addressed before a deal closes. The LOI should reflect this complexity. For deals in the $1M–$5M revenue range, the LOI typically establishes an enterprise value between 3.5x and 6x trailing EBITDA, defines the due diligence scope around client contracts and credentialing records, and sets a 60–90 day exclusivity window. Buyers using SBA 7(a) financing should note that lender requirements for a third-party business valuation and clean seller financials must be anticipated at the LOI stage. Sellers should use this document to protect against indefinite exclusivity, define what constitutes a material adverse change, and ensure that recruiter and account manager retention obligations are clearly scoped before they become post-close disputes.
Find Medical Staffing Agency Businesses to AcquireParties and Transaction Overview
Identifies the buyer entity, seller entity, and the legal structure of the proposed acquisition — whether an asset purchase or stock purchase. In medical staffing, asset purchases are most common because buyers want to avoid inheriting undisclosed wage-and-hour liabilities, worker misclassification claims, or prior licensing violations.
Example Language
This Letter of Intent is entered into by [Buyer Entity Name], a [State] LLC ('Buyer'), and [Seller Entity Name], a [State] S-Corporation ('Seller'), with respect to Buyer's proposed acquisition of substantially all operating assets of Seller's medical staffing business, including its clinician database, client contracts, trade name, and credentialing infrastructure, excluding cash, aged receivables older than 90 days, and any liabilities not expressly assumed by Buyer.
💡 Sellers should push back on blanket exclusions of liabilities and request a schedule of assumed liabilities be attached at LOI stage. Buyers should confirm whether Joint Commission accreditation, state staffing licenses, and MSP participation agreements are transferable under an asset structure, as some agreements require health system consent to assign.
Purchase Price and Valuation Methodology
Establishes the total enterprise value and how it was calculated, typically as a multiple of trailing twelve-month or trailing three-year average adjusted EBITDA. In medical staffing, EBITDA normalization must account for owner-operator compensation, personal vehicle and phone expenses, and any one-time pandemic-era revenue spikes from crisis-rate travel nurse contracts that are not representative of normalized operations.
Example Language
Buyer proposes a total enterprise value of $[X], representing approximately [4.5x] Seller's trailing twelve-month adjusted EBITDA of $[X], as preliminarily calculated from Seller's 2023 reviewed financial statements and adjusted for owner compensation above $[150,000], non-recurring travel nurse surge revenue in excess of normalized bill rates, and one-time legal and accounting expenses. Final purchase price is subject to adjustment based on due diligence findings and a quality of earnings review.
💡 Sellers should provide a detailed addback schedule at or before LOI signing to prevent buyers from renegotiating the multiple after due diligence. Buyers should specify whether the stated multiple applies to a normalized margin that excludes pass-through payroll — a common inflator in staffing agency revenue — and confirm the EBITDA basis reflects gross profit on staffing spreads, not total billings.
Deal Structure and Consideration
Defines how the purchase price will be paid — including cash at close, seller note, earnout, and any equity rollover. Medical staffing acquisitions frequently include earnout provisions tied to the retention of named hospital system clients or aggregate gross margin performance, given the risk that client contracts may not survive an ownership change.
Example Language
The purchase price shall be payable as follows: (i) $[X] in cash at closing, funded through a combination of Buyer equity and SBA 7(a) loan proceeds; (ii) a seller note of $[X] at [6%] annual interest, payable over [24] months, subordinated to senior SBA lender; and (iii) an earnout of up to $[X] payable over [24] months post-close, calculated as [20%] of gross profit generated from client accounts identified in Exhibit A that remain active and in good standing through the earnout period. Seller equity rollover of [15–20%] may be offered in lieu of a portion of the cash consideration in PE-backed structures.
💡 Sellers should negotiate earnout measurement metrics that are within their control during a transition period, such as gross profit per named account rather than aggregate EBITDA, which can be affected by buyer overhead allocations. Buyers should define 'active and in good standing' with specificity — including minimum monthly billing thresholds — to prevent disputes over whether a dormant hospital account qualifies for earnout credit.
Exclusivity and No-Shop Provision
Grants the buyer an exclusive negotiating window during which the seller agrees not to solicit or entertain competing offers. This is critical in medical staffing deals because sellers often receive inbound interest from roll-up platforms and should not be locked into exclusivity before a buyer has demonstrated financial capacity and familiarity with healthcare compliance requirements.
Example Language
Upon execution of this LOI, Seller agrees to a [75-day] exclusivity period during which Seller shall not solicit, initiate, or engage in discussions with any third party regarding the sale of the business. Buyer agrees to provide evidence of financing capacity, including a preliminary SBA lender indication of interest or proof of equity funds, within [10 business days] of LOI execution. Exclusivity may be extended by mutual written agreement for up to [30] additional days if due diligence is ongoing in good faith.
💡 Sellers should resist exclusivity periods exceeding 90 days without a clear milestone schedule tied to buyer deliverables. Buyers should include a provision allowing them to terminate exclusivity and walk away without penalty if material undisclosed liabilities — such as a pending wage-and-hour claim or licensing violation — are discovered within the first 30 days of due diligence.
Due Diligence Scope and Access
Defines the categories of information the buyer is entitled to review and the process for accessing sensitive materials including credentialing files, client contracts, and recruiter compensation agreements. Given the regulated nature of medical staffing, due diligence scope should explicitly include compliance documentation that goes beyond standard financial review.
Example Language
Seller shall provide Buyer and its advisors with reasonable access to: (i) three years of financial statements, payroll records, and accounts receivable aging reports; (ii) all executed client service agreements, MSP/VMS participation agreements, and hospital credentialing requirements; (iii) the agency's clinician database including licensure verification status, background check records, and competency assessments for all active placements; (iv) all state staffing licenses, tax registrations, and Joint Commission or accreditation certificates; (v) worker classification documentation for all 1099 and W-2 clinicians; and (vi) all pending or threatened litigation, regulatory inquiries, and wage-and-hour claims. Due diligence shall be conducted through a secure virtual data room and governed by the terms of the executed NDA.
💡 Buyers should request a compliance summary memo from the seller's healthcare attorney before signing the LOI to surface known issues early. Sellers should limit physical site visits and direct recruiter interviews until later in diligence to reduce staff disruption and minimize the risk of premature sale disclosure to key employees.
Representations and Conditions to Closing
Outlines the seller's material representations that, if breached, give the buyer the right to renegotiate or terminate. In medical staffing, standard representations should be expanded to cover compliance-specific matters unique to the industry.
Example Language
Seller represents that: (i) all active clinician placements are covered by executed client service agreements with current certificates of insurance; (ii) the agency holds all required state staffing licenses in jurisdictions where it places clinicians; (iii) no Joint Commission, state nursing board, or DOL investigation is pending or threatened; (iv) all clinicians classified as independent contractors meet applicable IRS and state-law tests for contractor status; and (v) no single client account represents more than [35%] of trailing twelve-month gross billings. Closing is conditioned upon Buyer's satisfactory completion of due diligence, SBA lender approval, and assignment or reissuance of material client contracts.
💡 Buyers should add a representation confirming that no key recruiter or account manager has given notice of resignation or been solicited by a competitor within the prior 90 days. Sellers should negotiate a materiality qualifier on the client concentration representation to avoid a technical breach if a hospital system temporarily increased utilization near the measurement date.
Confidentiality and Employee Notification
Addresses how the transaction will be kept confidential and when and how employees — particularly recruiters and account managers who are critical to agency value — will be informed of the pending sale.
Example Language
Both parties agree to maintain strict confidentiality regarding the existence and terms of this LOI and the proposed transaction. Seller shall not disclose the pending sale to any employee, client, or clinician without prior written consent of Buyer, except as required by law. The parties shall jointly develop an employee communication plan no later than [30 days] prior to closing, which shall include retention agreements or stay bonuses for identified key personnel, as mutually agreed. Seller shall not take any action to encourage or facilitate the departure of any recruiter, account manager, or credentialing specialist during the exclusivity period.
💡 Buyers should insist on identifying key personnel by name in a confidential exhibit and tying seller note payments to minimum retention rates through the earnout period. Sellers should ensure the communication plan respects their relationships with long-tenured recruiters and avoids creating anxiety that triggers voluntary departures before close.
Earnout Structure Tied to Named Client Retention
Medical staffing agencies derive substantial value from relationships with specific hospital systems or healthcare networks. Earnouts should be calculated on gross profit generated by named accounts — not aggregate EBITDA — to isolate client retention performance from buyer-driven cost changes. Define minimum monthly billing thresholds per account to distinguish active relationships from dormant ones, and set a clear cure period if a client temporarily reduces utilization.
Clinician Database Valuation and Transfer Mechanics
The proprietary ATS and credentialing database is often the most defensible competitive asset in a medical staffing agency. The LOI should specify that the database — including licensure verification records, competency files, and placement history — transfers as a core asset, confirm that the ATS software license is assignable, and address whether active clinician agreements need to be reissued under the buyer's entity to remain enforceable.
Worker Classification Indemnification
Misclassification of clinicians as independent contractors rather than employees is one of the most significant unquantified liabilities in a medical staffing acquisition. The seller should provide a specific indemnification for any pre-close worker classification claims, IRS audits, or state agency investigations, with an escrow holdback of 5–10% of purchase price held for 18–24 months to fund potential exposure.
License and Accreditation Transferability
State staffing agency licenses, Joint Commission accreditation, and MSP/VMS vendor agreements are often non-transferable or require advance notice and consent from the issuing authority or client. Buyers should make closing contingent on confirmation that all material licenses and accreditations can be maintained through a stock purchase or reissued promptly after an asset purchase, and sellers should provide a license transfer timeline as part of due diligence deliverables.
Seller Non-Compete Scope and Duration
Because medical staffing relationships are geography- and specialty-specific, the non-compete should be tailored to the agency's actual operating footprint rather than a broad national restriction. Specify the clinical disciplines covered (e.g., travel nursing, per diem RN, allied health), the geographic territory (e.g., counties or MSAs served), and a 3–5 year duration. SBA lenders will require an enforceable non-compete as a condition of loan approval.
Transition Services and Seller Involvement Post-Close
Owner-operators who serve as primary recruiters or sole relationship managers for top hospital accounts represent a key-person risk that the LOI should directly address. Define a minimum transition period of 6–12 months, specify whether the seller will remain in a consulting or employment capacity, and tie a portion of the seller note or earnout to the seller's active participation in client introductions and recruiter handoffs during the transition window.
Find Medical Staffing Agency Businesses to Acquire
Enough information to write a strong LOI on day one — free to join.
Medical staffing agencies in the lower middle market typically trade at 3.5x to 6x trailing adjusted EBITDA, with the range driven by the quality of client contracts, diversification of the client base, compliance infrastructure, and recurring revenue predictability. Agencies with signed multi-year master service agreements, Joint Commission accreditation, and a proprietary credentialing database of 500 or more active clinicians command the higher end of the range. Agencies with heavy client concentration — where one or two hospital systems represent 50% or more of billings — or owner-dependent recruiter relationships typically fall in the 3.5x to 4.5x range until those risks are mitigated.
Asset purchases are more common in lower middle market medical staffing transactions because buyers want to avoid inheriting undisclosed pre-close liabilities including wage-and-hour claims, worker misclassification exposure, and licensing violations. However, stock purchases are used in PE-backed roll-up deals where preserving Joint Commission accreditation, state staffing licenses, and MSP/VMS vendor agreements in their current form is operationally critical and difficult to transfer under an asset structure. Your healthcare M&A attorney should audit the transferability of all material licenses and contracts before choosing the acquisition structure.
Earnouts work best when tied to gross profit generated by named client accounts rather than aggregate EBITDA, which can be manipulated by buyer-side overhead allocations. Define a list of key hospital system clients in a confidential exhibit, set a minimum monthly billing threshold per account to confirm active status, and measure earnout performance quarterly over a 12–24 month window. Sellers should negotiate a cure period of 30–60 days if a named client temporarily reduces utilization due to census fluctuations rather than relationship deterioration, and should ensure earnout metrics are not affected by buyer decisions to change bill rates or staffing mix.
Before entering exclusivity, buyers should request a compliance summary from the seller covering: state staffing agency license status in all operating jurisdictions, Joint Commission or accreditation certificate currency, worker classification methodology for all 1099 clinicians, the status of any pending DOL, state labor agency, or IRS inquiries, and whether all active clinicians have current licensure verification and background checks on file. Discovering a licensing violation or open wage-and-hour claim after signing an LOI gives the buyer limited leverage and can result in either walking away and losing exclusivity costs or accepting risk that should have been priced into the deal at the outset.
Yes, medical staffing agencies are SBA 7(a) eligible, and this financing structure is frequently used in owner-operator acquisitions of agencies in the $1M–$5M revenue range. A typical SBA-financed deal requires a 10–20% buyer equity injection, allows a subordinated seller note of up to 10% of the purchase price, and funds the remaining balance through a 10-year SBA loan. SBA lenders will require a third-party business valuation, an enforceable seller non-compete, and a review of the agency's client contract quality and compliance history as part of the credit approval process. Buyers should engage an SBA lender with healthcare staffing experience early in the process, ideally before signing the LOI, to confirm loan eligibility and size.
Most medical staffing agency acquisitions take 90 to 150 days from signed LOI to closing, with the primary variables being SBA loan processing time, the complexity of client contract assignment or novation, and the outcome of the credentialing and compliance audit. Deals involving PE-backed buyers with committed capital and no SBA requirement can close in 60–75 days. Sellers should expect the due diligence phase to consume 45–60 days as buyers review clinician credentialing files, worker classification records, client service agreements, and three years of financial statements in detail.
More Medical Staffing Agency Guides
More LOI Templates
Get enough diligence data to write a confident LOI from day one.
Create your free accountNo credit card required
For Buyers
For Sellers